SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-001284
Filing Date
2019-03-15
Accepted
2019-03-15 07:01:41
Documents
5
Period of Report
2019-04-26
Effectiveness Date
2019-03-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2237983zdef14a.htm DEF 14A 314563
2 G643015.JPG g643015.jpg GRAPHIC 25254
3 G859925.JPG g859925.jpg GRAPHIC 5724
4 G27072BKI001.JPG g27072bki001.jpg GRAPHIC 166126
5 G27072BMI001.GIF g27072bmi001.gif GRAPHIC 67538
  Complete submission text file 0001047469-19-001284.txt   680610
Mailing Address 240 LEIGH FARM ROAD DURHAM NC 27707
Business Address 240 LEIGH FARM ROAD DURHAM NC 27707 919-806-4487
Dova Pharmaceuticals Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38135 | Film No.: 19682884
SIC: 2834 Pharmaceutical Preparations